> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Genetesis Cardia Imaging Platform Cleared
- URL: https://www.fdaweb.com/genetesis-cardia-imaging-platform-cleared/
- Published: 2019-03-22T12:00:00.000Z
- Updated: 2026-09-15T01:15:10.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5143678

FDA has cleared a Genetesis 510(k) for its cardiac imaging platform, which pairs its CardioFlux Magnetocardiograph with the integrated Faraday Analytical Cloud (FAC). The company says the new technology provides emergency room physicians and cardiologists with access to measure and visualize magnetic fields produced by the heart’s natural electrical activity. CardioFlux technology uses “optically pumped magnetometers” to eliminate the need for liquid helium cooling, it says. “CardioFlux data is sent securely to the Faraday Analytical Cloud, from which physicians can review the functional imaging data, access a comprehensive set of web services, and hospitals can leverage an integrated billing service,” it says.